Hologic, Inc.
(NASDAQ : HOLX)

( )
HOLX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. 0.44%161.510.7%$722.99m
MDTMedtronic Plc 0.25%119.130.6%$397.75m
ABTAbbott Laboratories 0.01%88.250.8%$359.28m
ISRGIntuitive Surgical, Inc. 0.18%598.292.4%$359.20m
TMOThermo Fisher Scientific, Inc. 0.48%336.801.0%$306.71m
BDXBecton, Dickinson & Co. -0.15%276.881.1%$261.21m
BSXBoston Scientific Corp. 1.48%43.201.1%$256.43m
SYKStryker Corp. 1.29%209.421.3%$232.66m
EWEdwards Lifesciences Corp. 0.76%238.591.2%$208.21m
ABMDABIOMED, Inc. 1.98%181.443.3%$204.09m
BAXBaxter International, Inc. 0.49%90.001.8%$203.74m
ALGNAlign Technology, Inc. 3.99%285.036.4%$197.46m
DXCMDexCom, Inc. 0.03%234.418.3%$175.81m
STESTERIS Plc (Ireland) 1.08%154.213.7%$172.62m
NVSTEnvista Holdings Corp. 1.69%31.930.0%$153.93m

Company Profile

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.